These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31754559)

  • 1. A Novel Approach to the Treatment of Pembrolizumab-induced Psoriasis Exacerbation: A Case Report.
    Monsour EP; Pothen J; Balaraman R
    Cureus; 2019 Oct; 11(10):e5824. PubMed ID: 31754559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: reinitiating pembrolizumab treatment after small bowel perforation.
    Beck TN; Kudinov AE; Dulaimi E; Boumber Y
    BMC Cancer; 2019 Apr; 19(1):379. PubMed ID: 31018834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis induced by first‑line pembrolizumab in metastatic non‑small cell lung cancer: A case report.
    Gatti F; Caruso G; Potenza C; Santini D; Petrozza V; Annetta A; Ceddia S; Cosimati A; Brandi M; Sorrentino V; Proietti I; Rossi L
    Oncol Lett; 2023 Jul; 26(1):311. PubMed ID: 37332334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atezolizumab-induced psoriasis in a patient with metastatic lung cancer-a case report.
    Mao M; Shi M; Li T; Wang Q; Wu L
    Transl Cancer Res; 2020 May; 9(5):3776-3782. PubMed ID: 35117743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pembrolizumab-Induced Rupioid Psoriasis Treated by Apremilast Without Interrupting the Ongoing Antineoplastic Treatment.
    Ambrogio F; Rubino L; Laface C; Cazzato G; Foti C
    Cureus; 2024 Feb; 16(2):e55249. PubMed ID: 38558625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Lung Adenocarcinoma with Long-Term Response after Late-Onset Pembrolizumab-Induced Acute Adrenal Insufficiency.
    Sonehara K; Tateishi K; Hirabayashi T; Araki T; Ikuyama Y; Machida R; Hanaoka M
    Case Rep Oncol; 2021; 14(1):1-7. PubMed ID: 33613234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Treatment of Afatinib-Refractory Non-Small Cell Lung Cancer with Uncommon Complex EGFR Mutations Using Pembrolizumab: A Case Report.
    Taniguchi Y; Yamamoto M; Ikushima H; Ohara S; Takeshima H; Sakatani T; Usui K
    Case Rep Oncol; 2019; 12(2):564-567. PubMed ID: 31427953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pembrolizumab-Induced Vitiligo in Esophageal Squamous Cell Carcinoma Patient With Durable Complete Response.
    Wilkins MC; Elgamal M; Rybkin II
    Cureus; 2021 Nov; 13(11):e19739. PubMed ID: 34938618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-PD1/PDL1 induced psoriasis.
    Voudouri D; Nikolaou V; Laschos K; Charpidou A; Soupos N; Triantafyllopoulou I; Panoutsopoulou I; Aravantinos G; Syrigos K; Stratigos A
    Curr Probl Cancer; 2017; 41(6):407-412. PubMed ID: 29096940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological Agents for Treating Atezolizumab-Induced Psoriasis in Small-Cell Lung Cancer: A Case Report.
    Fukui M; Chihara Y; Takahashi Y; Sai N; Doi H; Nakakubo Y; Saito M
    Cureus; 2024 May; 16(5):e61395. PubMed ID: 38947665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIHA and Pancytopenia as Complications of Pembrolizumab Therapy for Metastatic Melanoma: A Case Report.
    Ni D; AlZahrani F; Smylie M
    Case Rep Oncol; 2019; 12(2):456-465. PubMed ID: 31275137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Psoriasis Flare After Anti-Programmed Death Ligand 1 (PD-L1) Therapy for Metastatic Non-Small Cell Lung Cancer (NSCLC).
    Chia PL; John T
    J Immunother; 2016 Jun; 39(5):202-4. PubMed ID: 27163740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pembrolizumab-Induced Immune-Mediated Colitis in a Patient with Concurrent Clostridium Difficile Infection.
    Zhou C; Klionsky Y; Treasure ME; Bruno DS
    Case Rep Oncol; 2019; 12(1):164-170. PubMed ID: 31043955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with pembrolizumab after hypersensitivity reaction to nivolumab in a patient with hepatocellular carcinoma.
    Choi B; McBride A; Scott AJ
    Am J Health Syst Pharm; 2019 Oct; 76(21):1749-1752. PubMed ID: 31612928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant benefits of pembrolizumab in treating refractory advanced pulmonary sarcomatoid carcinoma: A case report.
    Chen P; Yu M; Zhang JL; Chen WY; Zhu L; Song Y; Jiang CY; Zhang S
    World J Clin Cases; 2020 Jul; 8(13):2876-2884. PubMed ID: 32742998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
    Hanna KS
    Pharmacotherapy; 2016 Nov; 36(11):e183-e188. PubMed ID: 27716999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis.
    Dafni U; Tsourti Z; Vervita K; Peters S
    Lung Cancer; 2019 Aug; 134():127-140. PubMed ID: 31319971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid.
    Swinkels OQ; Prins M; Kucharekova M; de Boo T; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
    Br J Dermatol; 2002 Apr; 146(4):621-6. PubMed ID: 11966693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy.
    Freites-Martinez A; Kwong BY; Rieger KE; Coit DG; Colevas AD; Lacouture ME
    JAMA Dermatol; 2017 Jul; 153(7):694-697. PubMed ID: 28467522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.